Export Ready — 
Cover Image

Hereditary Retinopathies Progress in Development of Genetic and Molecular Therapies /

The hereditary retinopathy, retinitis pigmentosa (RP), which affects 1 in 3,500 people worldwide, is the most common cause of registered visual handicap among those of the working age in developed countries. RP is a highly variable disorder where patients may develop symptomatic visual loss in early...

Full description

Saved in:
Bibliographic Details
Main Authors: Humphries, Pete. (Author, http://id.loc.gov/vocabulary/relators/aut), Humphries, Marian M. (http://id.loc.gov/vocabulary/relators/aut), Tam, Lawrence C. S. (http://id.loc.gov/vocabulary/relators/aut), Farrar, G. Jane. (http://id.loc.gov/vocabulary/relators/aut), Kenna, Paul F. (http://id.loc.gov/vocabulary/relators/aut), Campbell, Matthew. (http://id.loc.gov/vocabulary/relators/aut), Kiang, Anna-Sophia. (http://id.loc.gov/vocabulary/relators/aut)
Corporate Author: SpringerLink (Online service)
Format: Electronic eBook
Language:English
Published: New York, NY : Springer New York : Imprint: Springer, 2012.
Edition:1st ed. 2012.
Series:SpringerBriefs in Genetics, 1
Subjects:
Human genetics.
Gene therapy.
Ophthalmology.
Human Genetics.
Gene Therapy.
Online Access:https://doi.org/10.1007/978-1-4614-4499-2
Tags: Add Tag
No Tags, Be the first to tag this record!
Table of Contents:
  • Preface
  • Introduction
  • Gene-based Medicines directly targeting genetic defects and molecular pathologies common to multiple forms of disease
  • Molecular Medicines.

Similar Items